FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37491011000001102: Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Aug 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
346841000001116 Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
346851000001118 Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has AMP Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) true Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Is a Gefitinib 250mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Gefitinib true Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start